Rep. Walden Reactivates Investigation Into Top Opioid Manufacturers
January 15, 2020
January 15, 2020
WASHINGTON, Jan. 15 -- Rep. Greg Walden, R-Oregon, issued the following news release on Jan. 14:
Representative Greg Walden (R-OR) announced that he is reactivating an investigation into the role of top opioid manufacturers in the ongoing opioid crisis. Walden was joined by Representatives Brett Guthrie (R-KY) and Morgan Griffith (R-VA) in sending letters to Insys Therapeutics, Mallinckrodt Pharmaceuticals, and Purdue Pharma, pressing for further answers from the manufacturers follo . . .
Representative Greg Walden (R-OR) announced that he is reactivating an investigation into the role of top opioid manufacturers in the ongoing opioid crisis. Walden was joined by Representatives Brett Guthrie (R-KY) and Morgan Griffith (R-VA) in sending letters to Insys Therapeutics, Mallinckrodt Pharmaceuticals, and Purdue Pharma, pressing for further answers from the manufacturers follo . . .